CGMP/Finished Pharmaceuticals/Adulterated/Unapproved New Drug
Similar Posts
MJS Medicals – 11/03/2025
Unapproved New Drugs/Misbranded/BotoxOTC Monograph Reform: OTC Sunscreen Drugs – 12/15/2021
Webinar to discuss the deemed final order (DFO) for over-the-counter (OTC) sunscreen drugs and proposed order for OTC sunscreen drugsNew England Home Therapies Inc. Southborough, MA. 483 Issued 01/27/2016
Record Date 01/27/2016
FEI Number 1000120535
Firm Name New England Home Therapies Inc.
Record Type 483
State MA
Establishment Type Producer of Sterile Drug ProductsInfusion Pump Correction: ICU Medical, Inc. Issues Correction for Plum Duo Infusion System Due to Software Possibly Resulting in Pump Becoming Unresponsive
ICU Medical is correcting the Plum Duo infusion system due to pump software issues that may cause the device to become unresponsive.FDA grants accelerated approval to sunvozertinib for metastatic non-small cell lung cancer with EGFR exon 20 insertion mutations
On July 2, 2025, the Food and Drug Administration granted accelerated approval to sunvozertinib (Zegfrovy, Dizal (Jiangsu) Pharmaceutical Co., Ltd.) for adult patients with locally advanced or metastatic non-small cell lung cancer (NSCLC) with epidermal growth factor receptor (EGFR) exon 20 insertioDaewoo Pharmaceutical Co., Ltd. – 706371 – 07/02/2025
CGMP/Finished Pharmaceuticals/Adulterated